Zobrazeno 1 - 10
of 101
pro vyhledávání: '"H, Renges"'
Autor:
Djordje Atanackovic, J. Dahlke, Jens Panse, Francis Ayuk, Tatjana Zabelina, H Renges, Axel R. Zander, Arnon Nagler, N Kröger, Christine Wolschke, Avichai Shimoni, Heike Schieder
Publikováno v:
Bone Marrow Transplantation. 37:339-344
We investigated a dose-reduced conditioning regimen consisting of treosulfan and fludarabine followed by allogeneic stem cell transplantation (SCT) in 26 patients with secondary AML or MDS. Twenty patients were transplanted from matched or mismatched
Autor:
A R Zander, Christine Wolschke, J. Dahlke, W Krüger, Heike Schieder, H Renges, A Kruell, Tatjana Zabelina, N. Fehse, Rudolf Erttmann, Olga Waschke, F Ayuk, Axel Hinke, N Kröger, Hartmut Kabisch
Publikováno v:
Bone Marrow Transplantation. 37:155-163
We report the results of 84 patients with ALL after related (n = 46) or unrelated (n = 38) allogeneic SCT. Mean recipient age was 23 years (range: 1-60) and median follow-up was 18 months (range: 1-133). Forty-three patients were transplanted in CR1;
Autor:
H Renges, N Kröger, Tatjana Zabelina, N. Fehse, Heike Schieder, Boris Fehse, A R Zander, Hartmut Kabisch, A A Oyekunle, F Ayuk, Olga Waschke
Publikováno v:
Bone Marrow Transplantation. 37:45-50
We examined retrospectively 44 patients with refractory acute leukemia (acute myeloid leukemia (AML)/acute lymphoblastic leukemia=25/19) who underwent allogeneic transplantation at our center between 11/1990 and 04/2004. The median leukemic blasts wa
Autor:
N Kröger, Kai Gutensohn, L Cortes-Dericks, Axel R. Zander, William Krüger, H Renges, S Sonnenberg, T Dielschneider
Publikováno v:
Bone Marrow Transplantation. 29:727-730
We compared two doses of recombinant human granulocyte-stimulating factor (G-CSF) for stem cell mobilisation in 90 healthy donors for allogeneic stem cell transplantation in a retrospective analysis. Group I (n = 46) received 10 microg/kg G-CSF (filg
Autor:
Rudolf Erttmann, W Krüger, Ulrika M. Schade, F. Tögel, H Renges, N Stute, J Rischewski, S Sonnenberg, H Fiegel, F Ayuk, Tatjana Zabelina, N Kröger, C Löliger, A R Zander
Publikováno v:
Bone Marrow Transplantation. 29:683-689
One-hundred and two patients with good risk myeloid leukemia (CML first chronic phase or AML first CR) were transplanted from HLA-related donors after conditioning with (n = 45) or without anti-thymocyte globulin (ATG) (n = 57). One graft failure was
Autor:
Johanna Schrum, N Stute, W Krüger, Wolfgang Siegert, Hartmut Kabisch, A R Zander, Tatjana Zabelina, H Renges, N Kröger, Johannes Schetelig
Publikováno v:
Bone Marrow Transplantation. 28:643-647
We investigated the feasibility and efficacy of a fludarabine-based dose-reduced conditioning regimen followed by stem cell transplantation from related (n = 5) or unrelated HLA-matched donors (n = 7) in 12 patients with high risk MDS, who were not e
Autor:
U. Mayer, N Stute, Tatjana Zabelina, H Renges, A R Zander, S Sonnenberg, W Krüger, Walter Fiedler, Hartmut Kabisch, N Kröger, R. Sonnen, F. del Valle, R. Kuse, F. Finkenstein, K. Holstein, D Braumann, Bernd Metzner, H. Colberg, Rudolf Erttmann
Publikováno v:
Bone Marrow Transplantation. 26:711-716
To evaluate the efficacy and toxicity of two different etoposide (VP-16) dosages (30 or 45 mg/kg) in combination with busulfan/cyclophosphamide as conditioning therapy followed by stem cell transplantation in acute myeloid leukemia (AML), 90 patients
Autor:
G.F. Riedler, G. Nahler, N. Fuchs, E. Watz, U. Cassens, T. Meinertz, M.A. Brockmann, M.D. Kramer, F. Deisenhammer, G. Salvisberg, N. Schmitz, R. Huss, B. Rüssmann, Y. Bauer, K. Pantel, V. Kretschmer, K. Schmitt, G.H. Sigurdsson, E. Richter, H. Renges, H. Eichler, P. Kühnl, C. Ahlke, L.M. Williamson, W. Krüger, S. Strasser-Fuchs, B. Schiedlmeier, I. Wenger, R. Wallich, C. Beythien, W. Holzgreve, A. Leveringhaus, A. Morell, W.J. Zeller, H.T. Hassan, N. Kröger, B. Mamoli, S. Fruehauf, K.F. Waschke, C. Löliger, W. Zeller, M.R. Veldwijk, M. Kerowgan, S. Martin, G. Friedmann, R. Erttmann, H.U. Rieder, R. Haas, C. Jäger, K. Witter, A.R. Zander, M. Luginbühl, F. Fazekas, U.E. Nydegger, C. Rauhöft, P. Dreger, M. Kern, C. Lenz, C.A. Seiler, K. Gutensohn, D.V. Surbek, W. Zieger, W. Sibrowski
Publikováno v:
Transfusion Medicine and Hemotherapy. 26:I-V
Autor:
C.C. Löliger, C. Rauhöft, P. Kühnl, W. Zeller, A.R. Zander, H. Renges, W Krüger, R. Erttmann, N. Fuchs, Nicolaus Kröger, K. Gutensohn, H. T. Hassan, B Rüssmann
Publikováno v:
Transfusion Medicine and Hemotherapy. 26:85-90
Cytokines are involved in hematopoiesis and cell growth regulation. Many cytokines have the property of increasing the number of hematopoietic progenitor cells circulating in peripheral blood. Since it has been shown that peripheral blood progenitor
Autor:
Stockschläder M, H Bartels, H Renges, B Rüssmann, R. Kuse, N Kröger, W Krüger, G Wacker-Backhaus, N. Fuchs, M Dürken, Hartmut Kabisch, A R Zander, Rudolf Erttmann, S Hegewisch-Becker, Stefan S. Bielack, M de Wit, Gunter Schuch, D Braumann
Publikováno v:
Bone Marrow Transplantation. 22:1029-1033
We investigated an intensified conditioning regimen including fractionated total body irradiation (12 Gy), etoposide (30–45 mg/kg) and cyclophosphamide (120 mg/kg), followed by autologous (n = 5), allo-related (n = 13) or allo-unrelated (n = 6) bon